Bioavailability and corneal anti-inflammatory effect of topical suprofen.
The bioavailability in rabbit cornea and aqueous humor of an ophthalmic formulation of suprofen, a nonsteroidal anti-inflammatory drug, was evaluated following topical administration of a single dose to the eye. The drug penetrated rapidly into the uninflamed cornea with intact epithelium; highest levels occurred during the first 30 to 45 min after instillation and decreased thereafter. The bioavailability of suprofen in cornea and aqueous humor following administration of a 1.0% concentration was twice that produced by a 0.5% concentration of the drug. Topical application of multiple doses of suprofen failed to suppress polymorphonuclear leukocyte invasion of the cornea if treatment was started after the induction of inflammation. Suprofen therapy initiated prior to the induction of corneal inflammation and maintained into the post-inflammation period did produce a significant (P less than 0.01) decrease in the numbers of PMNs that invaded the inflamed cornea. There was no significant difference (P greater than 0.05) in the corneal anti-inflammatory effect achieved by the 0.5% and 1.0% concentrations of suprofen when administered according to this regimen.
D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism; D001682:Biological Availability; D003315:Cornea / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007634:Keratitis / Q000188:drug therapy*; D010666:Phenylpropionates / Q000378:metabolism*; D011817:Rabbits; D013496:Suprofen / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use
D010666:Phenylpropionates; D013496:Suprofen